Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paolo Borghetti

Showing results (111-120 of 130) with videos related to

Pageof 13
Sort By:
Critical Reviews in Oncology/Hematology|February 2, 2024
Management of patients with extensive small-cell lung cancer in the immunotherapy era: An Italian consensus through a Delphi approachGiovanni Luca Ceresoli, Giulio Rossi, Francesco Agustoni, et al.
Frontiers in Oncology|July 20, 2023
Unresectable stage III non-small cell lung cancer: could durvalumab be safe and effective in real-life clinical scenarios? Results of a single-center experiencePaolo Borghetti, Giulia Volpi, Giorgio Facheris, et al.
Clinical & Experimental Metastasis|November 8, 2021
The role of stereotactic body radiation therapy and its integration with systemic therapies in metastatic kidney cancer: a multicenter study on behalf of the AIRO (Italian Association of Radiotherapy and Clinical Oncology) genitourinary study groupCiro Franzese, Giulia Marvaso, Giulio Francolini, et al.
La Radiologia Medica|October 13, 2019
Is multidisciplinary management possible in the treatment of lung cancer? A report from three Italian meetingsDavide Franceschini, Alessio Bruni, Paolo Borghetti, et al.
La Radiologia Medica|February 12, 2024
High dose proton and photon-based radiation therapy for 213 liver lesions: a multi-institutional dosimetric comparison with a clinical perspectiveMarco Lorenzo Bonù, Luca Nicosia, Ana Turkaj, et al.
Plos One|November 2, 2019
Treatment paths for localised prostate cancer in Italy: The results of a multidisciplinary, observational, prospective study (Pros-IT CNR)Michela Buglione, Marianna Noale, Alessio Bruni, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|June 23, 2022
Impact of stereotactic body radiotherapy vs palliative radiotherapy on oncologic outcomes of patients with metastatic kidney cancer concomitantly treated with immune checkpoint inhibitors: a preliminary, multicentre experienceGiulio Francolini, Riccardo Campi, Vanessa Di Cataldo, et al.
Lung Cancer (Amsterdam, Netherlands)|January 12, 2020
Radiosurgery and fractionated stereotactic radiotherapy in oligometastatic/oligoprogressive non-small cell lung cancer patients: Results of a multi-institutional series of 198 patients treated with "curative" intentMichela Buglione, Barbara Alicja Jereczek-Fossa, Marco Lorenzo Bonù, et al.
Cancers|September 13, 2025
Oligometastatic Mesothelioma Treated with Ablative Radiotherapy (OMAR): A Multicenter StudyDavide Franceschini, Paolo Ghirardelli, Patricia Frrokaj, et al.
Critical Reviews in Oncology/Hematology|February 3, 2025
Navigating chemotherapy and immunotherapy in early-stage lung cancer. A critical review and statements from INTERACTION groupChiara Catania, Claudia Proto, Chiara Bennati, et al.
Pageof 13

Showing results (111-120 of 130) with videos related to

Sort By:
Pageof 13
Critical Reviews in Oncology/Hematology|February 2, 2024
Management of patients with extensive small-cell lung cancer in the immunotherapy era: An Italian consensus through a Delphi approachGiovanni Luca Ceresoli, Giulio Rossi, Francesco Agustoni, et al.
Frontiers in Oncology|July 20, 2023
Unresectable stage III non-small cell lung cancer: could durvalumab be safe and effective in real-life clinical scenarios? Results of a single-center experiencePaolo Borghetti, Giulia Volpi, Giorgio Facheris, et al.
Clinical & Experimental Metastasis|November 8, 2021
The role of stereotactic body radiation therapy and its integration with systemic therapies in metastatic kidney cancer: a multicenter study on behalf of the AIRO (Italian Association of Radiotherapy and Clinical Oncology) genitourinary study groupCiro Franzese, Giulia Marvaso, Giulio Francolini, et al.
La Radiologia Medica|October 13, 2019
Is multidisciplinary management possible in the treatment of lung cancer? A report from three Italian meetingsDavide Franceschini, Alessio Bruni, Paolo Borghetti, et al.
La Radiologia Medica|February 12, 2024
High dose proton and photon-based radiation therapy for 213 liver lesions: a multi-institutional dosimetric comparison with a clinical perspectiveMarco Lorenzo Bonù, Luca Nicosia, Ana Turkaj, et al.
Plos One|November 2, 2019
Treatment paths for localised prostate cancer in Italy: The results of a multidisciplinary, observational, prospective study (Pros-IT CNR)Michela Buglione, Marianna Noale, Alessio Bruni, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|June 23, 2022
Impact of stereotactic body radiotherapy vs palliative radiotherapy on oncologic outcomes of patients with metastatic kidney cancer concomitantly treated with immune checkpoint inhibitors: a preliminary, multicentre experienceGiulio Francolini, Riccardo Campi, Vanessa Di Cataldo, et al.
Lung Cancer (Amsterdam, Netherlands)|January 12, 2020
Radiosurgery and fractionated stereotactic radiotherapy in oligometastatic/oligoprogressive non-small cell lung cancer patients: Results of a multi-institutional series of 198 patients treated with "curative" intentMichela Buglione, Barbara Alicja Jereczek-Fossa, Marco Lorenzo Bonù, et al.
Cancers|September 13, 2025
Oligometastatic Mesothelioma Treated with Ablative Radiotherapy (OMAR): A Multicenter StudyDavide Franceschini, Paolo Ghirardelli, Patricia Frrokaj, et al.
Critical Reviews in Oncology/Hematology|February 3, 2025
Navigating chemotherapy and immunotherapy in early-stage lung cancer. A critical review and statements from INTERACTION groupChiara Catania, Claudia Proto, Chiara Bennati, et al.
Pageof 13